Sonire Therapeutics has raised $18m towards supporting the ongoing clinical advancement of its non-invasive thermal ablation tumour treatment system.
The Tokyo, Japan-headquartered company’s Series A financing round was led by Santé Ventures, with additional participation from investors including Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment.



Leave a Reply